231 related articles for article (PubMed ID: 7175835)
21. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
22. Continuous subcutaneous insulin infusion in an obese insulin-resistant pregnant woman with type II diabetes: accelerated fetal growth and neonatal complications.
Moore TR; Hollingsworth DR; Kolterman O; Nager C
Obstet Gynecol; 1987 Sep; 70(3 Pt 2):480-5. PubMed ID: 3627609
[TBL] [Abstract][Full Text] [Related]
23. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.
Meneghini L; Sparrow-Bodenmiller J
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298
[TBL] [Abstract][Full Text] [Related]
24. [Long-term use of portable insulin pumps to stabilize metabolism in labile diabetics and for euglycemic blood sugar regulation in pregnancy].
Berger W; Keller U; Straumann M; Clerc D; Fried M
Schweiz Med Wochenschr; 1983 May; 113(18):679-88. PubMed ID: 6408732
[No Abstract] [Full Text] [Related]
25. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
26. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy.
Gabbe SG; Carpenter LB; Garrison EA
Clin Obstet Gynecol; 2007 Dec; 50(4):1014-24. PubMed ID: 17982345
[TBL] [Abstract][Full Text] [Related]
27. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
28. [Diabetes mellitus: the role of metabolic control in the prevention of complications].
Gomez F; Chabot V
Schweiz Med Wochenschr; 1983 Sep; 113(38):1342-5. PubMed ID: 6415812
[TBL] [Abstract][Full Text] [Related]
29. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
30. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
Zisser H
Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
[TBL] [Abstract][Full Text] [Related]
31. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)].
Lambert AE; Buysschaert M; Van Halle B
Diabete Metab; 1979 Dec; 5(4):307-12. PubMed ID: 398299
[TBL] [Abstract][Full Text] [Related]
33. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
34. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
35. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
36. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
Giménez M; Conget I; Nicolau J; Pericot A; Levy I
Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
[TBL] [Abstract][Full Text] [Related]
37. Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus.
Bernasko J
J Matern Fetal Neonatal Med; 2007 Feb; 20(2):125-32. PubMed ID: 17437210
[TBL] [Abstract][Full Text] [Related]
38. Patient management of long-term continuous subcutaneous insulin infusion.
Johansson UB; Adamson U; Lins PE; Wredling R
J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion: the insulin pump.
De Nobel E
Neth J Med; 1984; 27(5):173-6. PubMed ID: 6374480
[No Abstract] [Full Text] [Related]
40. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
